Skip to main content
NCBI home page
CNS Drug Reviews logoLink to CNS Drug Reviews
. 2007 Sep 24;13(3):308–316. doi: 10.1111/j.1527-3458.2007.00021.x

CGP7930: A Positive Allosteric Modulator of the GABAB Receptor

C L Adams 1,2, A J Lawrence 2,3
PMCID: PMC6494120  PMID: 17894647

ABSTRACT

CGP7930 (3‐(3′,5′‐Di‐tert‐butyl‐4′‐hydroxy)phenyl‐2,2‐dimethylpropanol) is a positive allosteric modulator of the metabotropic GABAB receptor. CGP7930 has been found to modulate the GABAB receptor in the open, or high affinity, state increasing agonist affinity for the receptor and signal transduction efficacy following agonist stimulation. The GABAB heteromeric subunit B2, involved in signal transduction but not ligand binding, seems to be the site of action of CGP7930 and similar allosteric modulators. When administered alone in naïve animals, CGP7930 acts as an anxiolytic in rodents without other overt behavioral effects and has also been demonstrated to reduce self‐administration of nicotine, cocaine, or alcohol in rodents, suggesting that “fine tuning” of the GABAB receptor by positive allosteric modulators may be able to regulate abuse of these drugs. Baclofen, the GABAB agonist, is currently finding use in treating addiction and various other disorders, but this can result in off‐target effects and tolerance. CGP7930 when co‐administered with baclofen enhances its potency, which could in theory minimize deleterious effects. Further study of CGP7930 is required, but this compound, and others like it, holds potential in a clinical setting.

Keywords: Alcohol, Drug‐seeking, CGP7930, GABAB receptors

Full Text

The Full Text of this article is available as a PDF (499.6 KB).

Conflict of interest: The authors have no conflict of interest.

REFERENCES

  1. Addolorato G, Caputo F, Capristo E, Domenicali M, Bernardi M, Janiri L, Agabio R, Colombo G, Gessa GL, Gasbarrini G (2002) Baclofen efficacy in reducing alcohol craving and intake: A preliminary double‐blind randomized controlled study. Alcohol Alcohol 37:504‐508. [DOI] [PubMed] [Google Scholar]
  2. Addolorato G, Leggio L, Abenavoli L, Agabio R, Caputo F, Capristo E, Colombo G, Gessa GL, Gasbarrini G (2006) Baclofen in the treatment of alcohol withdrawal syndrome: A comparative study vs diazepam. Am J Med 119:13‐18. [DOI] [PubMed] [Google Scholar]
  3. Arias Montano JA, Martinez‐Fong D, Aceves J (1992) GABAB receptor activation partially inhibits N‐methyl‐D‐aspartate‐mediated tyrosine hydroxylase stimulation in rat striatal slices. Eur J Pharmacol 218:335‐338. [DOI] [PubMed] [Google Scholar]
  4. Asay MJ, Boyd SK (2006) Characterization of the binding of [3H]CGP54626 to GABAB receptors in the male bullfrog (Rana catesbeiana). Brain Res 1094:76‐85. [DOI] [PubMed] [Google Scholar]
  5. Bettler B, Tiao JY (2006) Molecular diversity, trafficking and subcellular localization of GABAB receptors. Pharmacol Ther 110:533‐543. [DOI] [PubMed] [Google Scholar]
  6. Binet V, Brajon C, Le Corre L, Acher F, Pin JP, Prezeau L (2004a) The heptahelical domain of GABAB2 is activated directly by CGP7930, a positive allosteric modulator of the GABAB receptor. J Biol Chem 279:29085‐29091. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Binet V, Goudet C, Brajon C, Le Corre L, Acher F, Pin JP, Prezeau L (2004b) Molecular mechanisms of GABAB receptor activation: New insights from the mechanism of action of CGP7930, a positive allosteric modulator. Biochem Soc Trans 32:871‐872. [DOI] [PubMed] [Google Scholar]
  8. Bowery N (1989) GABAB receptors and their significance in mammalian pharmacology. Trends Pharmacol Sci 10:401‐407. [DOI] [PubMed] [Google Scholar]
  9. Bucknam W (2007) Suppression of symptoms of alcohol dependence and craving using high‐dose baclofen. Alcohol Alcohol 42:158‐160. [DOI] [PubMed] [Google Scholar]
  10. Carai MA, Colombo G, Froestl W, Gessa GL (2004) In vivo effectiveness of CGP7930, a positive allosteric modulator of the GABAB receptor. Eur J Pharmacol 504:213‐216. [DOI] [PubMed] [Google Scholar]
  11. Chen Y, Menendez‐Roche N, Sher E (2006) Differential modulation by the GABAB receptor allosteric potentiator 2,6‐di‐tert‐butyl‐4‐(3‐hydroxy‐2,2‐dimethylpropyl)‐phenol (CGP7930) of synaptic transmission in the rat hippocampal CA1 area. J Pharmacol Exp Ther 317:1170‐1177. [DOI] [PubMed] [Google Scholar]
  12. Chen Y, Phillips K, Minton G, Sher E (2005) GABAB receptor modulators potentiate baclofen‐induced depression of dopamine neuron activity in the rat ventral tegmental area. Br J Pharmacol 144:926‐932. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Christopoulos A (2002) Allosteric binding sites on cell‐surface receptors: Novel targets for drug discovery. Nat Rev Drug Discov 1:198‐210. [DOI] [PubMed] [Google Scholar]
  14. Colombo G, Serra S, Vacca G, Carai MA, Gessa GL (2006) Baclofen‐induced suppression of alcohol deprivation effect in Sardinian alcohol‐preferring (sP) rats exposed to different alcohol concentrations. Eur J Pharmacol 550:123‐126. [DOI] [PubMed] [Google Scholar]
  15. Cryan JF, Kelly PH, Chaperon F, Gentsch C, Mombereau C, Lingenhoehl K, Froestl W, Bettler B, Kaupmann K, Spooren WPJM (2004) Behavioral characterization of the novel GABAB receptor‐positive modulator GS39783 (N,N′‐dicyclopentyl‐2‐methylsulfanyl‐5‐nitro‐pyrimidine‐4,6‐diamine): Anxiolytic‐like activity without side effects associated with baclofen or benzodiazepines. J Pharmacol Exp Ther 310:952‐963. [DOI] [PubMed] [Google Scholar]
  16. Flannery BA, Garbutt JC, Cody MW, Renn W, Grace K, Osborne M, Crosby K, Morreale M, Trivette A (2004) Baclofen for alcohol dependence: A preliminary open‐label study. Alcohol Clin Exp Res 28:1517‐1523. [DOI] [PubMed] [Google Scholar]
  17. Galvez T, Prezeau L, Milioti G, Franek M, Joly C, Froestl W, Bettler B, Bertrand HO, Blahos J, Pin JP (2000) Mapping the agonist‐binding site of GABAB type 1 subunit sheds light on the activation process of GABAB receptors. J Biol Chem 275:41166‐41174. [DOI] [PubMed] [Google Scholar]
  18. Gjoni T, Desrayaud S, Imobersteg S, Urwyler S (2006) The positive allosteric modulator GS39783 enhances GABAB receptor‐mediated inhibition of cyclic AMP formation in rat striatum in vivo . J Neurochem 96:1416‐1422. [DOI] [PubMed] [Google Scholar]
  19. Kornau HC (2006) GABAB receptors and synaptic modulation. Cell Tissue Res 326:517‐533. [DOI] [PubMed] [Google Scholar]
  20. Liang JH, Chen F, Krstew E, Cowen MS, Carroll FY, Crawford D, Beart PM, Lawrence AJ (2006) The GABAB receptor allosteric modulator CGP7930, like baclofen, reduces operant self‐administration of ethanol in alcohol‐preferring rats. Neuropharmacology 50:632‐639. [DOI] [PubMed] [Google Scholar]
  21. Mombereau C, Kaupmann K, Froestl W, Sansig G, Van Der Putten H, Cryan JF (2004) Genetic and pharmacological evidence of a role for GABAB receptors in the modulation of anxiety‐ and antidepressant‐like behavior. Neuropsychopharmacology 29:1050‐1062. [DOI] [PubMed] [Google Scholar]
  22. Mombereau C, Lhuillier L, Kaupmann K, Cryan JF (2007) GABAB receptor‐positive modulation‐induced blockade of the rewarding properties of nicotine is associated with a reduction in nucleus accumbens delta FosB accumulation. J Pharmacol Exp Ther 321:172‐177. [DOI] [PubMed] [Google Scholar]
  23. Olianas MC, Ambu R, Garau L, Onali P (2005) Allosteric modulation of GABA(B) receptor function in human frontal cortex. Neurochem Int 46:149‐158. [DOI] [PubMed] [Google Scholar]
  24. Onali P, Mascia FM, Olianas MC (2003) Positive regulation of GABA(B) receptors dually coupled to cyclic AMP by the allosteric agent CGP7930. Eur J Pharmacol 471:77‐84. [DOI] [PubMed] [Google Scholar]
  25. Orru A, Lai P, Lobina C, Maccioni P, Piras P, Scanu L, Froestl W, Gessa GL, Carai MA, Colombo G (2005) Reducing effect of the positive allosteric modulators of the GABA(B) receptor, CGP7930 and GS39783, on alcohol intake in alcohol‐preferring rats. Eur J Pharmacol 525:105‐111. [DOI] [PubMed] [Google Scholar]
  26. Paterson NE, Froestl W, Markou A (2004) The GABAB receptor agonists baclofen and CGP44532 decreased nicotine self‐administration in the rat. Psychopharmacology (Berl) 172:179‐186. [DOI] [PubMed] [Google Scholar]
  27. Pilc A, Nowak G (2005) GABABergic hypotheses of anxiety and depression: Focus on GABAB‐B receptors. Drugs Today (Barc) 41:755‐766. [DOI] [PubMed] [Google Scholar]
  28. Pin JP, Kniazeff J, Binet V, Liu J, Maurel D, Galvez T, Duthey B, Havlickova M, Blahos J, Prezeau L, et al (2004) Activation mechanism of the heterodimeric GABA(B) receptor. Biochem Pharmacol 68:1565‐1572. [DOI] [PubMed] [Google Scholar]
  29. Slattery DA, Markou A, Froestl W, Cryan JF (2005) The GABAB receptor‐positive modulator GS39783 and the GABAB receptor agonist baclofen attenuate the reward‐facilitating effects of cocaine: Intracranial self‐stimulation studies in the rat. Neuropsychopharmacology 30:2065‐2072. [DOI] [PubMed] [Google Scholar]
  30. Smith MA, Yancey DL, Morgan D, Liu Y, Froestl W, Roberts DC (2004) Effects of positive allosteric modulators of the GABAB receptor on cocaine self‐administration in rats. Psychopharmacology (Berl) 173:105‐111. [DOI] [PubMed] [Google Scholar]
  31. Urwyler S, Gjoni T, Kaupmann K, Pozza MF, Mosbacher J (2004) Selected amino acids, dipeptides and arylalkylamine derivatives do not act as allosteric modulators at GABAB receptors. Eur J Pharmacol 483:147‐153. [DOI] [PubMed] [Google Scholar]
  32. Urwyler S, Gjoni T, Koljatic J, Dupuis DS (2005) Mechanisms of allosteric modulation at GABAB receptors by CGP7930 and GS39783: Effects on affinities and efficacies of orthosteric ligands with distinct intrinsic properties. Neuropharmacology 48:343‐353. [DOI] [PubMed] [Google Scholar]
  33. Urwyler S, Mosbacher J, Lingenhoehl K, Heid J, Hofstetter K, Froestl W, Bettler B, Kaupmann K (2001) Positive allosteric modulation of native and recombinant gamma‐aminobutyric acid(B) receptors by 2,6‐Di‐tert‐butyl‐4‐(3‐hydroxy‐2,2‐dimethyl‐propyl)‐phenol (CGP7930) and its aldehyde analog CGP13501. Mol Pharmacol 60:963‐971. [PubMed] [Google Scholar]
  34. Urwyler S, Pozza MF, Lingenhoehl K, Mosbacher J, Lampert C, Froestl W, Koller M, Kaupmann K (2003) N,N′‐Dicyclopentyl‐2‐methylsulfanyl‐5‐nitro‐pyrimidine‐4,6‐diamine (GS39783) and structurally related compounds: Novel allosteric enhancers of gamma‐aminobutyric acidB receptor function. J Pharmacol Exp Ther 307:322‐330. [DOI] [PubMed] [Google Scholar]
  35. Vigot R, Barbieri S, Brauner‐Osborne H, Turecek R, Shigemoto R, Zhang YP, Lujan R, Jacobson LH, Biermann B, Fritschy JM, et al (2006) Differential compartmentalization and distinct functions of GABAB receptor variants. Neuron 50:589‐601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Walker BM, Koob GF (2007) The gamma‐aminobutyric acid‐B receptor agonist baclofen attenuates responding for ethanol in ethanol‐dependent rats. Alcohol Clin Exp Res 31:11‐18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. White JH, McIllhinney RA, Wise A, Ciruela F, Chan WY, Emson PC, Billinton A, Marshall FH (2000) The GABAB receptor interacts directly with the related transcription factors CREB2 and ATFx. Proc Natl Acad Sci U S A 97:13967‐13972. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from CNS Drug Reviews are provided here courtesy of Wiley

RESOURCES